Background. The incidence of MDR-TB becomes a health issue that must be addressed immediately. According to a 2014 WHO report, the incidence of deaths from MDR-TB reached 190,000 cases. In 2015 there were 250,000 deaths and in 2016 there were 240,000 deaths. The incidence of MDR-TB cases in Indonesia has been reported in 2013 reaching 1,094 cases. In 2014 there were 1,752 cases and in 2015 there were 1,860. MDR-TB events can occur due to failure in the treatment of previous TB. Objective. This research aim to know overview of tuberculosis treatment history in patient with multy drug resistant (MDR-TB) in RSUP Dr. M. Djamil Padang Methods.This research an descriptive study with cros sectional designed, based on medical record of MDR-TB patient in RSUP Dr. M. Djamil Padang in 2018-2019, a sample of 37 people sample using total sampling and it was analyzed by univariate analysis. Result. The result of this research showed the characteristics of MDR-TB were found most in the age group of 35-44 years(27%), male gender (64,9%), self imployed (35,1%). with the most history of treatment in the form of relapsing cases (32,4%). Conclusion. the conclusion of this study is the patient with MR-TB in RSUP Dr. M. Djamil Padang dominated by age of 35-44 years old, male and self imployed and the history of TB treatment in MDR-TB patients founnd the most cases of relaps
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.